An Outpatient Study Investigating Non-prescription Treatments for COVID-19

Stopped early · Phase 2 · Has a placebo group

Conditions studied: COVID-19

In brief

This is a platform study to investigate the effectiveness of a variety of non-prescription approaches for the treatment of non-hospitalized adults recently tested positive for COVID-19.

Key facts

Study ID

NCT04621149

Run by

Profact, Inc.

People needed

10

Starts

2020-11-15

Expected to finish

2022-03-31

Last updated by the study team

2022-09-30

Who can join

Age: 20 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Signed and dated informed consent form
• Stated willingness to comply with all study procedures and availability for the duration of the study
• Male or female, aged 20-70
• Confirmed diagnosis of COVID-19 by positive COVID-19 test. Symptoms of a mild degree such that hospitalization is not required. Within 7 days of symptom onset.
• Ability to drink at least 1 liter of water daily and be willing to adhere to the study regimen

You may not qualify if…

• COVID-19 symptoms of a severe enough nature that requires hospitalization
• Pregnancy or lactation
• Diagnosis of diabetes mellitus
• currently taking paroxetine or digoxin
• Individuals with diabetes mellitus

Where it is running

• AZ Good Health Center — Tempe, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.